Education

2003/09–2007/06 College of Life Science and Technology, Huazhong Agricultural University, Major: Biotechnology, Bachelor’s Degree

2006/09–2012/06 National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural University, Major: Biochemistry and Molecular Biology, Ph.D. (combined Master-Doctoral program)

Work Experience

2021/12–Present Institute of Biomedical Innovation, Nanchang University, Professor

2017/12–2021/12 Institute of Life Science, Nanchang University, Associate Professor

2012/07–2017/12 Institute of Life Science, Nanchang University, Associate Professor, lecturer

2011/03–2011/06 Department of Biology, Humboldt-Universität zu Berlin, Visiting Scholar

Academic Services

· National Science and Technology Expert Database (2021–Present)

· Ministry of Education Science and Technology Evaluation and Review Expert Database (2023–Present)

· National Natural Science Foundation of China Peer Review Expert (2020–Present)

· Standing Committee Member, Reproductive Pharmacology Committee, Chinese Pharmacological Society (2024–2028)

· Member, Interdisciplinary Frontier Group, Family Planning Branch, Chinese Medical Association (2020–2029)

· Committee Member, Safe Contraception Committee, Maternal and Child Health Research Association (2019–2028)

· Youth Committee Member, Jiangxi Society of Biochemistry and Molecular Biology (2020–Present)

· Council Member, Jiangxi Society of Physiological Sciences (2022–2027)

· Guest Associate Editor, Frontiers in Endocrinology (2022–Present)

Awards and Honors

· 2025: Second Prize of Natural Science Award, Jiangxi Provincial Science and Technology Award (Ranked 1st)

· 2025: Second Prize of Natural Science Award, National Maternal and Child Health Science and Technology Award (Ranked 2nd)

· 2025: Second Prize of Scientific and Technological Achievement Award, National Maternal and Child Health Science and Technology Award (Ranked 2nd)

· 2025: National Silver Award, China International College Students Innovation Competition (Supervisor)

· 2025: Jiangxi Provincial Outstanding Master’s Thesis Award (Supervisor)

· 2024: Jiangxi Provincial Outstanding Master’s Thesis Award (Supervisor)

· 2023: Second Prize of Medical Science and Technology Award, Jiangxi Medical Science and Technology Award (Ranked 2nd)

· 2022: Third Prize, National Undergraduate Life Science Competition (Supervisor)

· 2021: Bronze Award, National Undergraduate Basic Medical Innovation Competition (National Level) (Supervisor)

· 2021: Third Prize of Natural Science Award, Jiangxi Science and Technology Award (Ranked 2nd)

· 2018: Nomination Award, 19th Royan International Research Award (Ranked 1st)

Additional Information

1. Chinese Invention Patent: Application of Lysine 317 Succinylated Lactate Dehydrogenase C as a Biomarker or Target for Asthenozoospermia (ZL202310894712.1). Inventors: Luo Tao, Yuan Yuan, Tian Yan, Chen Houyang. Grant Date: 2024/05/14.

2. Chinese Invention Patent: An Immunogen for Preparing Succinylation Site-Specific Antibody of Lactate Dehydrogenase C, Its Preparation Method and Application (ZL202310905585.0). Inventors: Luo Tao, Tian Yan, Yuan Yuan, Chen Houyang, Ding Jing, Wang Houpeng. Grant Date: 2024/05/14.

3. Chinese Invention Patent: Immunogen for Preparing mPRα Monoclonal Antibody (ZL201910552308.X). Inventors: Luo Tao, Zeng Xuhui, Chen Houyang, Peng Zhen, Cheng Yimin. Grant Date: 2021-08-24.

The research group is dedicated to interdisciplinary studies in reproductive medicine, reproductive biology, environmental science, and materials science. The team explores the mechanisms by which ion channels, membrane receptors, single-gene mutations, post-translational modifications, and environmental factors regulate reproductive function and contribute to the pathogenesis of infertility. They also develop corresponding precision diagnostic and therapeutic systems. Previous work includes establishing a high-throughput sperm ion channel detection platform, discovering various novel reproductive-related lysine acylation modifications, and developing a genetic diagnosis and treatment system for sperm motility disorders, providing new theoretical foundations and potential strategies for the precision treatment of infertility-related diseases. Specific research directions include:

1) Identification of infertility diagnostic and therapeutic targets based on novel acylation modifications (e.g., lactylation, crotonylation, succinylation) and single-gene mutations.

2) Mechanisms of emerging environmental pollutants (e.g., endocrine disruptors and nanoplastics) affecting reproductive health and development of intervention strategies.

3) Development of infertility intervention strategies based on targeted drug delivery using nanomaterials and cell-penetrating peptides, as well as AI-assisted drug screening.